Pathologic complete response (pCR) following neoadjuvant therapy has been associated
with improved event-free survival (EFS) and overall survival (OS) in early-stage breast …

Purpose: While various studies have highlighted the prognostic significance of pathologic
complete response (pCR) after neoadjuvant chemotherapy (NAT), the impact of additional …

Background Achieving a pathological complete response (pCR) is believed to correlate with
oncological outcomes in human epidermal growth factor receptor-2-positive (HER2+) breast …

Breast cancer is a heterogeneous pathology, but the genomic basis of its variability remains
poorly understood in populations other than Caucasians. Here, through DNA and RNA …

Background Long-term consequences of cancer treatments in young women, and especially
fertility issues, are gaining attention as survival rates increase. Breast cancer is the most …

Objective. Earlier research has illustrated prognostic significance of pathologic complete
response (pCR) in neoadjuvant therapy (NAT) for breast cancer, whereas correlation …

Background Younger women (age≤ 40 years) with breast cancer undergoing neoadjuvant
chemotherapy (NAC) have higher rates of pathologic complete response (pCR); however, it …

Background and objectives The relationship between age and the outcome of breast cancer
neoadjuvant chemotherapy (NAC) remains controversial, and little is known about the …

Background Young women with breast cancer are determined to present poorer survival
compare with elderly patients. Therefore, identifying the clinical prognostic factors in young …

Identification of CXCR4 and CXCL10 as Potential Predictive Biomarkers in Triple Negative
Breast Cancer (TNBC) - PMC Back to Top Skip to main content NIH NLM Logo Access keys …